Entheogen Field Map — Voices, Organizations & Landscape

Harmonism Location: Wheel of Presence → Entheogen Pillar Scope: A map of the contemporary psychedelic/entheogen/sacred-plant field — its voices, organizations, and lineages.

Foundational Intellectual Lineage

• Aldous Huxley — The Doors of Perception; perennialist-phenomenological framing of the psychedelic experience
• R. Gordon Wasson — Ethnomycology; the Mazatec velada; brought psilocybin mushrooms to Western awareness
• Albert Hofmann — LSD synthesis (1938/1943); later philosophical reflection on entheogens
• Stanislav Grof — Transpersonal cartography; holotropic breathwork; perinatal matrices; the elder architect of consciousness mapping through psychedelics
• Terence McKenna — Speculative-visionary framing (stoned ape hypothesis, timewave); influential but epistemically uneven
• Ralph Metzner — Harvard lineage carried into ecological and alchemical directions
• Ram Dass (Richard Alpert) — Harvard lineage carried into contemplative practice (Be Here Now)
• Huston Smith — Perennialist philosophical lens; Cleansing the Doors of Perception
• Alexander Shulgin — Rediscovery of MDMA; PiHKAL and TiHKAL; systematic exploration of phenethylamines and tryptamines
• Claudio Naranjo — Early integration of iboga and ayahuasca into psychotherapy; bridged indigenous practice and clinical work

Living Voices — Clinical & Scientific Axis

Tier 1: Field-Defining

• Robin Carhart-Harris (UCSF, formerly Imperial College) — Leading neuroscientific theorist; entropic brain hypothesis; REBUS model (Relaxed Beliefs Under Psychedelics). Scientific correlate of mystical opening.
• Matthew Johnson (Johns Hopkins) — Psilocybin for addiction and depression; bridges clinical and philosophical
• Roland Griffiths (Johns Hopkins, d. 2023) — Among the most important figures in legitimizing psilocybin within mainstream science. Legacy continues through the Hopkins center.
• Rachel Yehuda (Mount Sinai) — Trauma biology credibility applied to MDMA research
• David Nutt (Imperial College) — Drug policy reform; neuropsychopharmacology
• Rick Doblin (MAPS founder) — 40+ years building infrastructure for clinical legitimacy; the most important policy figure in the field’s modern history

Tier 2: Major Contributors

• Gül Dölen — Neuroplasticity research; psychedelics reopening critical periods of social learning (one of the most theoretically significant neuroscience findings in recent years)
• Nolan Williams (Stanford) — Accelerated therapeutic protocols
• Michael Bogenschutz — Psilocybin for alcohol use disorder
• Alan K. Davis — Clinical trials, 5-MeO-DMT research
• Stephen Ross (NYU) — Psilocybin for end-of-life anxiety
• Ben Sessa (UK) — MDMA-assisted therapy
• Joshua Siegel (Hopkins) — Psilocybin and brain connectivity desynchronization
• Ben Kelmendi — OCD and psychedelics
• Amy Lehrner — VA psychedelic-assisted therapy for veterans

Key Popularizers & Bridge Figures

• Michael Pollan — How to Change Your Mind; single biggest mainstream popularization event of the last decade
• James Fadiman — The Psychedelic Explorer’s Guide; microdosing protocol framework
• Paul Stamets — Mycologist; psilocybin advocate; commercial operations (Fungi Perfecti); most publicly visible mushroom voice
• Gabor Maté — Trauma-informed clinical framing applied to ayahuasca work

Living Voices — Philosophical & Transpersonal Axis

• Alberto Villoldo (Four Winds Society) — Embodied shamanic practice mapped to energy centers; Q’ero and Amazonian lineages. Already integrated into Harmonism via eight-chakra system. A primary cartography.
• Dennis McKenna — Ethnobotany; more empirically grounded than Terence
• Jeremy Narby — The Cosmic Serpent; DNA-vision hypothesis connecting molecular biology with ayahuasca phenomenology
• Chris Bache — LSD and the Mind of the Universe; most serious modern attempt at transpersonal cartography through sustained high-dose sessions
• Amanda Feilding (Beckley Foundation) — Bridges philosophical and scientific; instrumental in enabling Imperial College research; consciousness-science champion
• Benny Shanon — The Antipodes of the Mind; most rigorous phenomenological analysis of ayahuasca cognition from philosophy-of-mind standpoint
• Graham Hancock — Popularizer of entheogenic origins-of-consciousness thesis; broad reach but less rigorous

Indigenous & Sacred-Traditional Lineages

Ayahuasca Traditions

• Shipibo people (Peruvian Amazon) — Primary lineage most Westerners encounter; time-honored plant-spirit shamanism; icaros (healing songs); pattern cosmology representing the oneness of creation
• Santo Daime / União do Vegetal — Syncretic Brazilian ayahuasca churches; formalized sacramental container
• Mestizo curanderismo — Mixed-lineage healers throughout Upper Amazon (Peru, Colombia, Ecuador)

Psilocybin Mushrooms

• Mazatec tradition — María Sabina’s lineage (Oaxaca, Mexico); the original indigenous container for Western psilocybin encounter

Peyote / Mescaline

• Native American Church — Peyote sacrament; legal religious exemption in the US
• Wixárika / Huichol (Mexico) — Peyote pilgrimage tradition; among the oldest continuous ceremonial uses

San Pedro / Huachuma

• Q’ero people (Peru) — Primary carriers of Andean mesa tradition; San Pedro ceremony; direct descendants of Inca lineage. Villoldo’s primary indigenous source.

Iboga

• Bwiti tradition (Gabon) — Iboga as sacrament; initiatory and healing contexts; 24+ hour journey; considered a “reset” for mind, body, spirit. Ibogaine blocks the cardiac hERG channel and prolongs the QT interval to the point of ventricular arrhythmia; the documented deaths cluster twelve to seventy-six hours after the dose, inside and just beyond the journey this line describes, from the long-lived metabolite noribogaine. It is not a practice a reader undertakes; outside continuous cardiac monitoring it is the most lethal agent on this map

Western Bridge Figures (Serious Lineage Work)

• Alberto Villoldo (Q’ero and Amazonian)
• Rak Razam (Aya: Awakenings)
• Gabor Maté (trauma-informed ayahuasca)
• Hamilton Souther and established Western-trained curanderos in Iquitos

Organizations

Research Institutions

• Johns Hopkins Center for Psychedelic and Consciousness Research — Premier academic node
• Imperial College Centre for Psychedelic Research (London) — Carhart-Harris legacy; Nutt’s base
• UC Berkeley Center for the Science of Psychedelics — Third major academic hub
• Mount Sinai — Yehuda’s trauma-focused MDMA work

Non-Profit Research & Advocacy

• MAPS (Multidisciplinary Association for Psychedelic Studies) — Founded 1986; most important organization in the field; incubated Lykos Therapeutics for MDMA; hosts Psychedelic Science conference
• Beckley Foundation (Amanda Feilding) — Foundational funder and research partner
• Usona Institute — Non-profit psilocybin drug development; counterweight to for-profit model
• Heffter Research Institute — Funds rigorous research; historically enabled Hopkins and NYU studies

Commercial / Pharma

• COMPASS Pathways — Psilocybin; publicly traded; pharma-oriented
• Gilgamesh Pharmaceuticals — Bretisilocin (GM-2505); acquired by AbbVie for up to $1.2B in 2025 (first major pharma entry)
• Cybin (now Helus) — Psychedelic drug development
• Delix Therapeutics — Non-psychedelic neuroplasticity analogs (compounds without the subjective trip); key company to track in the non-hallucinogenic frontier
• Lykos Therapeutics — MAPS-incubated MDMA drug development; FDA rejected application in 2024 over methodological concerns

Policy & Reform

• Drug Policy Alliance — Broader drug policy reform
• Students for Sensible Drug Policy — Grassroots
• State-level programs: Oregon Measure 109, Colorado Natural Medicine Health Act

Conferences

• Psychedelic Science (MAPS) — Flagship global conference (Denver 2025)
• ICPR (Interdisciplinary Conference on Psychedelic Research) — Europe’s most scientifically rigorous gathering
• ISRP (International Society for Research on Psychedelics) — Academic society
• Breaking Convention (UK) — Broad multidisciplinary

Media & Analysis

• Psychedelic Alpha (Josh Hardman) — Best independent analytical newsletter covering commercial and regulatory landscape
• Blossom Analysis — Conference and research tracking

Key Structural Tensions (2026)

1. Pharma-medicalization vs. sacred-access: The central conflict in the field. FDA-pathway (COMPASS, AbbVie/Gilgamesh, Cybin) versus decriminalization and state-regulated programs (Oregon, Colorado).
2. Reductionist vs. transpersonal framing: Clinical trials isolate pharmacological mechanism; indigenous and transpersonal traditions insist the subjective-spiritual dimension is the medicine.
3. Non-psychedelic analogs: Delix and others developing compounds that deliver neuroplasticity without the experiential journey — challenges the mystical-experience hypothesis.
4. Indigenous sovereignty vs. Western extraction: Ongoing tension around cultural appropriation, biopiracy, and commercialization of sacred traditions.
5. FDA setbacks: Lykos MDMA rejection (2024) raised the bar for trial design and shifted timelines.

MDMA — Positioning Note

MDMA is a purely synthetic empathogen — no indigenous ceremonial lineage, no plant-spirit relationship, no traditional container. Derived from safrole (sassafras oil); substituted phenethylamine; rediscovered by Shulgin in 1976; therapeutic legitimacy through the clinical-pharmacological pathway (Shulgin → MAPS → Phase 2/3 trials → trauma-processing model).

Harmonist positioning: Outside the five cartographies as substance (modern synthetic, no lineage); inside them as territory (the Anāhata Heart-axis is what every cartography converges on naming as primary cultivational site — kardia, qalb, the Bhakti devotional Heart, munay, the Chinese Heart-Shen seat). Properly applied as both therapeutic instrument for targeted trauma work and as Heart-register transpersonal vehicle when intention is set right, within sustained practice and the discipline of rare-and-prepared use. Bears a Jing cost the Taoist framework reads precisely as serotonergic depletion and post-use Shen disturbance.

Full canonical treatment: MDMA.

Harmonism Integration Notes

Voices most coherent with Harmonic Realism: - Grof — cartography of consciousness - Villoldo — embodied shamanic practice mapped to energy centers - Carhart-Harris — entropic brain as scientific correlate of mystical opening - Bache — sustained transpersonal exploration - Shipibo / Q’ero lineages — indigenous cosmology treating entheogenic encounter as diagnostic and energetic

Epistemological mapping: The clinical-pharma axis operates at the rational-empirical layer — necessary but insufficient. The full entheogen encounter requires sensory → rational → experiential → mystical layers of the Harmonic Epistemology. The indigenous traditions naturally operate across all four layers simultaneously.

Wheel of Presence location: Entheogens as a practice within the broader context of consciousness work — not isolated pharmacology but embedded within Breath, Peace (Ajna), and Love (Anahata) as the three essential practices. The entheogenic encounter is a catalyst, not a substitute, for the daily cultivation of presence.